Central Nervous System Diseases  >>  LMTX (hydromethylthionine)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
LMTX (hydromethylthionine) / TauRx
NCT01626391 / 2011-005292-17: Safety Study of TRx0237 in Patients Already Taking Medications for Mild and Moderate Alzheimer's Disease

Terminated
2
9
Europe
TRx0237, Placebo
TauRx Therapeutics Ltd
Alzheimer's Disease
03/13
03/13

Download Options